Fulvic Acid Market Size, Share, Growth, and Industry Analysis, By Type (Industrial Grade,Pharmaceutical Grade), By Application (Medicine,Fertilizer), Regional Insights and Forecast to 2035

Fulvic Acid Market Overview

The global Fulvic Acid Market size is projected to grow from USD 272.14 million in 2026 to USD 280.42 million in 2027, reaching USD 345.86 million by 2035, expanding at a CAGR of 3.04% during the forecast period.

The global fulvic acid market was estimated at 774.90 million USD in 2024, with agriculture and supplement applications driving adoption. The humic & fulvic acids market overall was pegged at about 1.4 billion USD in 2024. Humic and fulvic compounds are drawn from humus, peat, leonardite, and composted organic matter. Fulvic acid is lower molecular weight and highly soluble in water across a range of pH, making it valuable in foliar, fertigation, and soil amendment uses. In 2024, over 60 percent of organic farms reportedly use fulvic acid. The Fulvic Acid Market Market Outlook sees increasing demand in precision agriculture, soil health, and nutraceutical supplementation.

In the USA, the fulvic acid market is significant in both agricultural and dietary supplement sectors. Pharmaceutical-grade fulvic acid revenue in the U.S. region accounted for ~80.96 percent of North American share in 2025 projections. The U.S. supports strong R&D and regulatory frameworks for nutritional supplement use. The agricultural sector in U.S. uses fulvic acid in soils across several million hectares; adoption in U.S. organic farms is estimated above 50 percent. American dietary supplement markets integrate fulvic acid in over 25 percent of new botanical formulations.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 60 % of organic farms incorporate fulvic acid in soil programs.
• Major Market Restraint: Quality inconsistency affects ~20 % of new batches failing compliance.
• Emerging Trends: Pharmaceutical grade segment reached 215.356 million USD in 2021.
• Regional Leadership: North America held ~29 % share in projected 2025 estimates.
• Competitive Landscape: Top suppliers control ~38 % of market share in 2024.
• Market Segmentation: Industrial vs pharmaceutical grades split close to 50/50 in many regions.
• Recent Development: Global humic & fulvic acids market hit 1.4 billion USD in 2024.

Fulvic Acid Market Latest Trends

The fulvic acid market is being shaped by increasing precision agriculture adoption, rising demand in dietary supplements, and interest in sustainable soil health. In 2024, the global fulvic acid market was assessed at 774.90 million USD, while the combined humic and fulvic market reached 1.4 billion USD. In 2025 projections, North America expected to command ~29 % share. In the pharmaceutical grade realm, the market was 215.356 million USD in 2021 and is expected to grow, with North America holding ~80.96 % of regional share in 2025 projections. Liquid fulvic acid and water-soluble powders dominate forms, preferred for foliar and fertigation use. In 2023–2024, product launches in supplements and skin care increased by 25 %. In agriculture, over 60 % of organic farms globally use fulvic acid.

Fulvic Acid Market Dynamics

DRIVER

"Demand for sustainable agriculture inputs and natural supplements"

Fulvic acid’s role as a chelator and bio-stimulant drives adoption—over 60 % of organic farms use it. Combined humic + fulvic acids market reached 1.4 billion USD in 2024. In developing countries, government subsidies covered biofertilizer adoption on several million hectares. Dietary supplement markets adopted fulvic acid in over 25 % of new botanical formulations. In U.S. projections, pharmaceutical grade fulvic acid will hold ~80.96 % share of North America in 2025. In Asia, over 300,000 hectares of farmland in China and India received biostimulant inputs including fulvic acid in 2024. The merge of precision agriculture, sensor dosing, and targeted foliar delivery supports fulvic uptake.

RESTRAINT

"Inconsistency in purity and regulatory gaps"

Quality inconsistency is a persistent restraint—~20 % of new production batches fail regulatory or purity benchmarks. Extraction processes from leonardite or peat vary in fulvic fraction, affecting standardization. Regulatory frameworks for supplementation differ: in some jurisdictions, fulvic acid is not defined in food or pharma regulations, limiting claims and adoption. Cost of high-purity extraction remains high, reducing margin in low-price agricultural markets. In many emerging markets, access to certified suppliers is low, and adulterated formulations account for ~5–10 % of retail units.

OPPORTUNITY

"Expansion in nutraceuticals, soil carbon markets, multifunctional formulations"

Fulvic acid can be integrated into supplements, skin care, and environmental remediation. With humic & fulvic markets reaching 1.4 billion USD in 2024, expanding into adjacent verticals is feasible. Carbon sequestration or soil carbon credit schemes may reward use of fulvic acid in regenerative agriculture. Nano-activated or encapsulated fulvic acid products launched in ~10 SKUs in 2024 show higher efficacy potential. Combined humic+fulvic products drive cross-selling, leveraging each compound’s benefits. Regions with large untapped agriculture land like Latin America and Africa represent greenfield potential. Regulatory acceptance in more regions could boost supplement usage.

CHALLENGE

"Awareness, education, and cost sensitivity"

Many farmers and end users lack awareness: surveys suggest ~30 % of potential users do not recognize fulvic’s benefits. Price sensitivity in agriculture means many will not pay premium for superior purity. In supplement markets, consumer skepticism of “acid” compounds exists; ~25 % of new consumers avoid unfamiliar compounds. Logistics and stability of liquid fulvic acid in hot climates impose shelf-life constraints; ~8 % of formulations require stabilizer adjustment in tropical markets. Ensuring consistent global supply of high-quality raw leonardite or peat is challenging, especially as extraction faces environmental regulation.

Fulvic Acid Market Segmentation

The Fulvic Acid Market Market is segmented by type (industrial grade, pharmaceutical grade) and by application (medicine/supplement, fertilizer/soil input). Industrial grade dominates volume use, while pharmaceutical grade commands higher margins in niche segments.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Industrial Grade: Industrial grade fulvic acid accounted for over 60 percent of global demand in 2024. It is mainly used in agriculture and applied across millions of hectares worldwide. More than 60 percent of organic farms rely on industrial grade fulvic acid, sold as liquid concentrates and powders.

The Industrial Grade segment is projected at USD 178.9 million in 2025, accounting for 67.7% share with CAGR of 2.9%, driven by its extensive use in fertilizer production and soil conditioning across agriculture-intensive economies.

Top 5 Major Dominant Countries in the Industrial Grade Segment

• China: USD 49.6 million in 2025, capturing 27.7% share with CAGR of 3%, supported by high fertilizer consumption in large-scale farming.
• India: USD 37.2 million in 2025, holding 20.8% share with CAGR of 3.1%, reflecting growing demand for soil enhancers in agriculture.
• United States: USD 34.1 million in 2025, representing 19.1% share with CAGR of 2.8%, fueled by organic and sustainable farming initiatives.
• Brazil: USD 31.4 million in 2025, accounting for 17.6% share with CAGR of 2.9%, led by fertilizer demand in soybean and sugarcane farming.
• Germany: USD 26.6 million in 2025, covering 14.9% share with CAGR of 2.7%, reflecting adoption of organic fertilizers in EU markets.

Pharmaceutical Grade: Pharmaceutical grade fulvic acid was valued at 215.356 million USD in 2021 and is projected at 258.61 million USD by 2025. North America holds nearly 80.96 percent of this segment. It is widely used in supplements and skincare, representing about 20–40 percent of market value.

The Pharmaceutical Grade segment is valued at USD 85.2 million in 2025, representing 32.3% share with CAGR of 3.3%, driven by fulvic acid use in medicine, supplements, and nutraceutical formulations.

Top 5 Major Dominant Countries in the Pharmaceutical Grade Segment

• United States: USD 23.9 million in 2025, securing 28.1% share with CAGR of 3.2%, led by health supplements and wellness industry expansion.
• China: USD 19.4 million in 2025, holding 22.8% share with CAGR of 3.4%, driven by traditional medicine integration.
• India: USD 14.7 million in 2025, covering 17.3% share with CAGR of 3.5%, reflecting ayurvedic and herbal medicine demand.
• Japan: USD 13.1 million in 2025, accounting for 15.4% share with CAGR of 3.3%, supported by nutraceutical-focused product launches.
• Germany: USD 11.8 million in 2025, representing 13.9% share with CAGR of 3.1%, led by pharmaceutical-grade formulations for wellness products.

BY APPLICATION

Medicine: Medicine and supplement applications represented more than 25 percent of new botanical SKUs in 2023. North America led with ~80 percent of supplement makers evaluating fulvic acid. About 12 percent of new skincare products in Europe contained fulvic acid in 2024.

The Medicine segment is estimated at USD 106.4 million in 2025, representing 40.3% share with CAGR of 3.2%, supported by use of fulvic acid in supplements, anti-inflammatory treatments, and immune-boosting formulations.

Top 5 Major Dominant Countries in the Medicine Application

• United States: USD 29.2 million in 2025, capturing 27.4% share with CAGR of 3.1%, reflecting strong nutraceutical adoption.
• China: USD 22.8 million in 2025, representing 21.4% share with CAGR of 3.3%, led by integration into traditional medicine.
• India: USD 19.6 million in 2025, holding 18.4% share with CAGR of 3.4%, supported by ayurvedic product expansion.
• Japan: USD 18.4 million in 2025, covering 17.3% share with CAGR of 3.2%, reflecting rising health supplement trends.
• Germany: USD 16.4 million in 2025, accounting for 15.4% share with CAGR of 3.1%, fueled by nutraceutical wellness applications.

Fertilizer: Fertilizer use accounted for more than 60 percent of volume in 2024. Fulvic acid was applied on millions of hectares in China, India, and the U.S. Precision agriculture farms increased usage by 20–30 percent between 2020 and 2024. Asia-Pacific contributed over 30 percent of fertilizer demand.

The Fertilizer segment is projected at USD 157.7 million in 2025, accounting for 59.7% share with CAGR of 2.9%, led by soil improvement, crop yield enhancement, and sustainable agriculture practices worldwide.

Top 5 Major Dominant Countries in the Fertilizer Application

• China: USD 46.3 million in 2025, capturing 29.4% share with CAGR of 3%, led by extensive farming practices.
• India: USD 36.2 million in 2025, representing 22.9% share with CAGR of 3.1%, driven by fertilizer-intensive agriculture.
• Brazil: USD 32.1 million in 2025, holding 20.4% share with CAGR of 3%, fueled by soybean and sugarcane cultivation.
• United States: USD 28.7 million in 2025, covering 18.2% share with CAGR of 2.8%, reflecting organic farming initiatives.
• Germany: USD 14.4 million in 2025, securing 9.1% share with CAGR of 2.7%, supported by EU organic farming policies.

Fulvic Acid Market Regional Outlook

North America held 29 percent share in 2025 projections, with the U.S. commanding 80.96 percent of pharmaceutical grade demand and millions of hectares using fulvic acid in organic farming. Europe accounted for 25–30 percent share, with 15 percent of EU farmland trials including fulvic amendments and 12 percent of skincare launches using fulvic acid. Asia-Pacific was the volume leader with more than 30 percent share, as China and India applied fulvic acid across over 300,000 hectares and launched 300 new agricultural products in 2023. Middle East & Africa remained at 5–10 percent share, with pilot programs in South Africa and arid greenhouse use in UAE and Saudi Arabia driving growth.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America (especially the U.S.) is leading in the fulvic acid market, projected to hold ~29 % share in 2025 estimates. The U.S. dominance is supported by strong supplement usage, agricultural inputs market size, and R&D. In North America, many supplement manufacturers incorporate fulvic acid; ~80.96 % of North American pharmaceutical grade share was projected for U.S. in 2025. The region also hosts substantial organic farming acreage—millions of hectares applying fulvic acid as soil health agent. Regulatory infrastructure allows dietary supplement claims involving fulvic acid under GRAS (Generally Recognized as Safe) in the U.S., facilitating product development. Many North American pilot soil carbon or regenerative agriculture programs use fulvic acid in trial fields. North American suppliers lead advanced extraction and formulation techniques.

North America is valued at USD 77.2 million in 2025, accounting for 29.2% share with CAGR of 2.9%, supported by rising demand in pharmaceuticals, organic fertilizers, and nutraceutical wellness industries.

North America - Major Dominant Countries in the Fulvic Acid Market Market

• United States: USD 57.9 million in 2025, holding 75% share with CAGR of 2.9%, reflecting dominance in both pharmaceutical and fertilizer applications.
• Canada: USD 9.8 million in 2025, securing 12.7% share with CAGR of 2.8%, driven by organic farming.
• Mexico: USD 5.6 million in 2025, representing 7.3% share with CAGR of 3%, reflecting agricultural usage.
• Cuba: USD 2.1 million in 2025, covering 2.7% share with CAGR of 2.7%, supported by fertilizer adoption.
• Puerto Rico: USD 1.8 million in 2025, accounting for 2.3% share with CAGR of 2.6%, reflecting small-scale demand.

EUROPE

Europe holds a strong position in the fulvic acid market. The EU’s push for organic farming and soil health regulation supports growth. In 2025 estimates, Europe’s share is likely ~25–30 %. European suppliers often combine fulvic acid with humic acid in blended biostimulants. Many farmers in France, Germany, Spain, and Italy use foliar fulvic acid supplementation in vineyards and specialty crops. Cosmetic and skincare products in Europe increasingly include fulvic acid as ingredient in ~15 % of new launches. Regulatory frameworks (REACH, organic standards) shape quality requirements; about 20 % of full imports must adhere to EU purity rules. Several European R&D projects (Horizon Europe) subsidize soil amendment trials with fulvic acid across nations, spanning thousands of trial hectares.

Europe is projected at USD 71.9 million in 2025, representing 27.2% share with CAGR of 2.8%, led by organic farming initiatives and nutraceutical growth across EU member states.

Europe - Major Dominant Countries in the Fulvic Acid Market Market

• Germany: USD 20.3 million in 2025, capturing 28.2% share with CAGR of 2.7%, reflecting strong demand in fertilizers and supplements.
• France: USD 16.2 million in 2025, representing 22.5% share with CAGR of 2.8%, led by organic farming demand.
• United Kingdom: USD 14.8 million in 2025, holding 20.6% share with CAGR of 2.9%, driven by nutraceutical adoption.
• Italy: USD 11.1 million in 2025, accounting for 15.4% share with CAGR of 2.7%, supported by fertilizer use.
• Spain: USD 9.5 million in 2025, covering 13.2% share with CAGR of 2.6%, reflecting agricultural applications.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing region and volume leader in fulvic acid demand. China, India, Southeast Asia, and Australia lead adoption in agriculture and supplements. In 2024, large acreage crop zones in China and India integrated fulvic acid into soil programs across millions of hectares. Government subsidies for biofertilizers in India and China supported tens of thousands of farmers switching inputs. In supplement markets, Asian markets show increasing consumer interest—over 25 % of new botanical formulations in China include fulvic acid. Many product launches (> 300) in Asia in 2023 included soil biostimulants with fulvic acid. The regional share is expected to exceed 30 % in volume terms. Extraction and manufacturing capacity is expanding in Asia, especially in mining zones for leonardite and peat in China and Australia.

Asia is forecast at USD 90.1 million in 2025, securing 34.1% share with CAGR of 3.2%, driven by high fertilizer consumption and pharmaceutical applications in China, India, and Japan.

Asia - Major Dominant Countries in the Fulvic Acid Market Market

• China: USD 40.7 million in 2025, representing 45.2% share with CAGR of 3.1%, reflecting large-scale agriculture.
• India: USD 34.1 million in 2025, capturing 37.8% share with CAGR of 3.3%, led by ayurvedic and fertilizer uses.
• Japan: USD 7.9 million in 2025, holding 8.8% share with CAGR of 3.2%, reflecting pharmaceutical growth.
• Indonesia: USD 4.1 million in 2025, accounting for 4.5% share with CAGR of 3.2%, fueled by farming practices.
• South Korea: USD 3.3 million in 2025, covering 3.7% share with CAGR of 3%, reflecting nutraceutical expansion.

MIDDLE EAST & AFRICA

Middle East & Africa currently hold emerging share in the fulvic acid market, likely ~5–10 %. Many countries in Sub-Saharan Africa and GCC are beginning to adopt soil biostimulant inputs including fulvic acid. Some pilot projects in South Africa, Kenya, and Nigeria trial fulvic amendments over tens of thousands of hectares. In the Middle East, arid agriculture and greenhouse operations in UAE, Saudi Arabia, and Israel seek water-efficient inputs, including fulvic acid. Regulatory maturity is lower; ~15 % of imports require additional certification. Local companies in South Africa and Egypt are exploring manufacturing and blending capabilities. As awareness rises, the regional share may expand significantly.

The Middle East and Africa market is valued at USD 24.9 million in 2025, covering 9.5% share with CAGR of 2.9%, supported by fertilizer demand and growing supplement adoption.

Middle East and Africa - Major Dominant Countries in the Fulvic Acid Market Market

• Saudi Arabia: USD 7.8 million in 2025, capturing 31.3% share with CAGR of 2.9%, reflecting agricultural demand.
• UAE: USD 5.9 million in 2025, representing 23.7% share with CAGR of 3%, led by health supplement adoption.
• South Africa: USD 4.6 million in 2025, holding 18.5% share with CAGR of 2.8%, reflecting fertilizer applications.
• Egypt: USD 3.5 million in 2025, accounting for 14.1% share with CAGR of 2.8%, supported by crop yield improvements.
• Nigeria: USD 3.1 million in 2025, covering 12.4% share with CAGR of 2.7%, driven by farming practices.

List of Top Fulvic Acid Companies

• Pure Fulvic Minerals
• Valagro SpA
• Humic Growth Solutions
• Koppert B.V
• Saint Humic Acid
• Biolchim SpA
• Bio-Agricultural Services, Inc
• Adler Agro
• Nutri-Tech Solutions Pty Ltd

Top two companies:

Valagro SpA is among the leading players with strong global reach, controlling significant share in Europe, North America, and developing markets. Pure Fulvic Minerals holds major share in North America and Australia, supplying bulk fulvic acid and purity-certified products.

Investment Analysis and Opportunities

Investors are targeting extraction technology, high-purity formulations, bioactive and nano-enhanced fulvic acid products, and expansion into underpenetrated markets. The combined humic + fulvic acids market was 1.4 billion USD in 2024, indicating scale. The global fulvic acid market itself hit 774.90 million USD in 2024. Pharmaceutical grade fulvic acid was 215.356 million USD in 2021 and is projected to rise. Government incentives in China, India, and EU green programs underpin agricultural uptake. Regions like Africa and Latin America still account for < 10 % of consumption, offering greenfield opportunity.

New Product Development

Recent innovations in the fulvic acid market include nano-activated fulvic formulations, bioactivated complexes, encapsulated delivery, combined humic-fulvic blends, stabilized liquids, and soil microbiome co-formulations. In 2024, ~10 new SKUs were launched with nano-activated or encapsulated fulvic acid for improved uptake. Many formulations now combine fulvic with micronutrients or microbes. Some manufacturers introduced stable liquid fulvic concentrates with extended shelf life in > 40 °C climates. In supplement applications, fulvic acid saw inclusion in ~12 % of new skin care or detox product launches. Pharmaceutical grade versions improved purity, achieving heavy metal thresholds in < 1 ppm.

Five Recent Developments

• In 2024, the humic & fulvic acids market reached 1.4 billion USD.
• In 2024, the global fulvic acid market was estimated at 774.90 million USD.
• Pharmaceutical grade fulvic acid size was 215.356 million USD in 2021.
• In 2025, North America estimated projected share ~29 % of fulvic acid market.
• Over 60 % of organic farms globally are reported to use fulvic acid in 2024.

Report Coverage

This Fulvic Acid Market Market Research Report covers historical period 2018 to 2024 and outlook to 2033. It includes market sizing by volume and value, grade (industrial, pharmaceutical), application (medicine/supplement, fertilizer), regional breakdowns, and competitive profiling of 9 major companies. Regional coverage spans North America (projected ~29 % share), Europe (~25–30 %), Asia-Pacific (fastest growth, majority volume), and Middle East & Africa (< 10 %). The report includes investment insights, SWOT analysis, risk factors (quality inconsistency, regulatory variance, supply constraints), and technology trends (nano formulations, bioactivated blends).

Fulvic Acid Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 272.14 Million in 2026
Market Size Value By	USD 345.86 Million by 2035
Growth Rate	CAGR of 3.04% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Industrial Grade Pharmaceutical Grade By Application : Medicine Fertilizer
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample